Mechanistic analyses determine that CXCL8 and its receptors contribute to the survival of CRC cells, mainly by reducing the survival pressure of tumor cells and helping them become resistant to apoptosis before and after invading the blood. The gene discussed is CXCL8; the disease is neoplasm.